GOT2 and pancreatic ductal adenocarcinoma: The knockdown of GOT2 in pancreatic ductal adenocarcinoma resulted in an increased production of ROS, which led to the cyclin-dependent kinase inhibitor p27-dependent senescence (Yang et al., 2018).